Australia markets closed

Chimeric Therapeutics Limited (CHM.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.03000.0000 (0.00%)
At close: 03:57PM AEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Cash flows from investing activities
Investments in property, plant and equipment
-537.855
-112.193
-537.855
-5,307
Purchases of investments
-40
-
-40
-
Net cash used for investing activities
-564.878
-112.193
-564.878
-5,304
Cash flows from financing activities
Debt repayment
-4,087
-2,225
-4,087
-892.031
Common stock issued
14,899
2,577
14,899
39,300
Common stock repurchased
-1,309
-88.819
-1,309
-2,715
Net cash used provided by (used for) financing activities
9,504
253.376
9,504
36,541
Net change in cash
-4,191
-16,165
-4,191
22,402
Cash at beginning of period
22,410
18,382
22,410
0.1
Cash at end of period
18,382
2,363
18,382
22,410
Free cash flow
Capital expenditure
-537.855
-112.193
-537.855
-5,307
Free cash flow
-13,668
-16,418
-13,668
-14,142